Compounded tirzepatide vs Mounjaro: what's different and what it costs
By PacificRx editorial team · Prices checked
The short answer
Mounjaro is Eli Lilly's FDA-approved tirzepatide for type 2 diabetes, listed at about $1,100 per month without insurance. For weight management, Lilly sells the same molecule as Zepbound. Compounded tirzepatide at PacificRx starts at $149/month plus a $30/month doctor & care-team fee after an online clinician review; it is not FDA-approved and is not the branded product.
Buy tirzepatide onlineSide by side
Third-party prices are from the sources below as of 2026-11-15 and can change; confirm them at the source. PacificRx prices are read from the current catalog.
Mounjaro and Zepbound are the same molecule
Mounjaro and Zepbound both contain tirzepatide. Mounjaro is labeled for blood-sugar control in adults with type 2 diabetes; Zepbound is labeled for chronic weight management and obstructive sleep apnea with obesity. Insurance coverage usually follows the labeled use.
PacificRx prescribes compounded preparations made by licensed U.S. pharmacies for an individual patient. A compounded preparation is not the branded product, is not an FDA-approved generic, and has not been reviewed by the FDA for safety, effectiveness or quality. A clinician decides whether it is appropriate for you.
Cost without insurance
Without coverage, Mounjaro's list price is roughly $1,100 per month. For people paying themselves for weight management, Lilly's Zepbound self-pay program ($299–$449/month by dose) is usually the lower-cost branded route.
PacificRx's compounded tirzepatide starts at $149/month plus a $30/month doctor & care-team fee, with higher dose tiers up to $399/month for the medication.
How buying tirzepatide online works at PacificRx
You complete a medical intake online, see the plan price before checkout, and authorize your card. The card is captured only if a licensed clinician approves a prescription; otherwise the hold is released. Medication ships free from a licensed U.S. pharmacy, and no insurance is needed.
Questions
Is Mounjaro approved for weight loss?
No. Mounjaro is FDA-approved for type 2 diabetes. The same molecule is approved for chronic weight management as Zepbound.
Is compounded tirzepatide the same as Mounjaro?
No. It shares the active ingredient but is a compounded preparation, not the branded product, and it is not FDA-approved.